The healthcare community is intrigued by retatrutide, a new dual GIP and GLP-1 target that’s showing remarkable results in early trials . This compound works by replicating natural hormones to affect appetite and promote feelings of satisfaction , ultimately contributing to substantial fat reduction . While still under evaluation and not readily